Gastroenterology

Gastroenterology

Volume 142, Issue 4, April 2012, Pages 886-896.e9
Gastroenterology

Original Research
Basic and Translational—Alimentary Tract
Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells

https://doi.org/10.1053/j.gastro.2011.12.047Get rights and content

Background & Aims

MicroRNAs (miRNAs) can promote or inhibit tumor growth and are therefore being developed as targets for cancer therapies. They are diverse not only in the messenger RNAs (mRNA) they target, but in their production; the same hairpin RNA structure can generate mature products from each strand, termed 5p and 3p, that can bind different mRNAs. We analyzed the expression, functions, and mechanisms of miR-28-5p and miR-28-3p in colorectal cancer (CRC) cells.

Methods

We measured levels of miR-28-5p and miR-28-3p expression in 108 CRC and 49 normal colorectal samples (47 paired) by reverse transcription, quantitative real-time polymerase chain reaction. The roles of miR-28 in CRC development were studied using cultured HCT116, RKO, and SW480 cells and tumor xenograft analyses in immunodeficient mice; their mRNA targets were also investigated.

Results

miR-28-5p and miR-28-3p were down-regulated in CRC samples compared with normal colon samples. Overexpression of miRNAs in CRC cells had different effects and the miRNAs interacted with different mRNAs: miR-28-5p altered expression of CCND1 and HOXB3, whereas miR-28-3p bound NM23-H1. Overexpression of miR-28-5p reduced CRC cell proliferation, migration, and invasion in vitro, whereas miR-28-3p increased CRC cell migration and invasion in vitro. CRC cells overexpressing miR-28 developed tumors more slowly in mice compared with control cells, but miR-28 promoted tumor metastasis in mice.

Conclusion

miR-28-5p and miR-28-3p are transcribed from the same RNA hairpin and are down-regulated in CRC cells. Overexpression of each has different effects on CRC cell proliferation and migration. Such information has a direct application for the design of miRNA gene therapy trials.

Section snippets

Colorectal Samples

Eighty-five CRC samples and 26 normal colorectal tissue samples (of which 24 were paired) were collected between 2003 and 2008 at the University Hospital of Ferrara in Ferrara, Italy (first sample set). Forty-two tumors were classified as microsatellite stable (MSS), and 43 tumors were classified as microsatellite unstable (MSI) (Supplementary Methods). For a confirmation set of samples, we obtained 23 paired samples of tumor and adjacent colorectal tissue that were collected between 2002 and

miR-28-5p and miR-28-3p Are Down-regulated in CRC

Expression levels of miR-28-5p and miR-28-3p were analyzed by quantitative real-time polymerase chain reaction (PCR) in 85 human CRC specimens and 26 normal human colorectal specimens. In order to ensure that the reference gene snRNA U6 does not change between normal and tumor samples, we calculated the mean Ct values as 2−Ct. Levels of U6 did not differ between normal and tumor tissue, 2−CtTumor/2−CtNormal = 0.94 (P = .41) (Supplementary Figure 2). Both miRNA-28-5p and miR-28-3p were

Discussion

In the present study, we analyzed 2 independent sets of human CRC samples, for a total of 108 (47 paired with normal tissue), and found significant down-regulation of both mature miR-28 forms. Our study is the first to show down-regulation of miR-28 in cancer. In the literature, only 1 study extensively analyzed miR-28 function in cancer, namely in myeloproliferative neoplasms. Girardot et al identified miR-28 overexpression in platelets of BCR-ABL–negative myeloproliferative neoplasm patients

Acknowledgments

The authors thank Sue Moreau from the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for English language editing of the manuscript. The authors also thank Dr Thomas Schmittgen from Ohio State University, Columbus OH, and Dr Ramiro Magno and Dr Stan Marée from John Innes Center, United Kingdom, for technical advice on qRT-PCR data analyses.

Drs Nicoloso and Spizzo are currently at the Division of Experimental Oncology, CRO, National Cancer Institute,

References (37)

  • A. Jemal et al.

    Cancer statistics, 2010

    CA Cancer J Clin

    (2010)
  • G.A. Calin et al.

    Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

    Proc Natl Acad Sci U S A

    (2002)
  • C.M. Croce

    Causes and consequences of microRNA dysregulation in cancer

    Nat Rev Genet

    (2009)
  • W.K. Wu et al.

    MicroRNA in colorectal cancer: from benchtop to bedside

    Carcinogenesis

    (2011)
  • M.A. Lea

    Recently identified and potential targets for colon cancer treatment

    Future Oncol

    (2010)
  • S. Griffiths-Jones et al.

    miRBase: microRNA sequences, targets and gene nomenclature

    Nucleic Acids Res

    (2006)
  • S.A. Bustin et al.

    The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

    Clin Chem

    (2009)
  • S. Lefever et al.

    RDML: structured language and reporting guidelines for real-time quantitative PCR data

    Nucleic Acids Res

    (2009)
  • Cited by (170)

    • The importance of hsa-miR-28 in human malignancies

      2023, Biomedicine and Pharmacotherapy
    • Serum MicroRNAs: -28-3p, -31-5p, -378a-3p, and -382-5p as novel potential biomarkers in acute lymphoblastic leukemia

      2022, Gene Reports
      Citation Excerpt :

      The miR-28 gene is located at 3q28 and has one of the most commonly altered genes in lymphoid malignancies (Bartolomé-Izquierdo et al., 2017). MiR-28 has increased expression in breast and kidney tumors (Yang et al., 2011) and decreased expression in neoplasms derived from germ cells (Bartolomé-Izquierdo et al., 2017), liver cancer (Shi and Teng, 2015), and colorectal (Almeida et al., 2012). Changes in miR-28 expression in cancers are associated with tumor growth, metastasis, invasion, recurrence, and decreased survival in patients (Almeida et al., 2012; Shi and Teng, 2015; Zhou et al., 2016).

    • Enhancement of myogenic differentiation and inhibition of rhabdomyosarcoma progression by miR-28-3p and miR-193a-5p regulated by SNAIL

      2021, Molecular Therapy Nucleic Acids
      Citation Excerpt :

      Similar to miR-193a-5p, miR-28-3p also exerts effects on tumor proliferation and survival. It inhibits the growth of non-Hodgkin lymphoma35 but, surprisingly, promotes colorectal carcinoma,17 which suggests that it may play a different role in different tumor types. It may also regulate the survival of cardiomyocytes.36

    View all citing articles on Scopus

    Conflicts of interest The authors disclose no conflicts.

    Funding M.I.A. is supported by a PhD fellowship (SFRH/BD/47031/2008) from Fundação para a Ciência e Tecnologia, Portugal. G.A.C. is supported as a fellow by The University of Texas MD Anderson Cancer Center Research Trust and The University of Texas System Regents Research Scholar. Work in Dr Calin’s laboratory is supported in part by grants from the National Institutes of Health (CA135444), the US Department of Defense, and the Pancreatic Cancer Action Network (2009 Seena Magowitz AACR Pilot Grant). STR DNA fingerprinting was done by the Cancer Center Support grant funded Characterized Cell Line core, NCI # CA16672.

    View full text